[go: up one dir, main page]

FI20050027L - Ei-terapeuttisesti käytettäviä trombiini-inhibiittoreita - Google Patents

Ei-terapeuttisesti käytettäviä trombiini-inhibiittoreita Download PDF

Info

Publication number
FI20050027L
FI20050027L FI20050027A FI20050027A FI20050027L FI 20050027 L FI20050027 L FI 20050027L FI 20050027 A FI20050027 A FI 20050027A FI 20050027 A FI20050027 A FI 20050027A FI 20050027 L FI20050027 L FI 20050027L
Authority
FI
Finland
Prior art keywords
thrombin inhibitors
therapeutic
therapeutic thrombin
inhibitors
thrombin
Prior art date
Application number
FI20050027A
Other languages
English (en)
Swedish (sv)
Other versions
FI120690B (fi
Inventor
John M Maraganore
Jo-Ann M Jablonski
Paul R Bourdon
Original Assignee
Biogen Idec Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogen Idec Inc filed Critical Biogen Idec Inc
Publication of FI20050027L publication Critical patent/FI20050027L/fi
Application granted granted Critical
Publication of FI120690B publication Critical patent/FI120690B/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/02Linear peptides containing at least one abnormal peptide link
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81Protease inhibitors
    • C07K14/815Protease inhibitors from leeches, e.g. hirudin, eglin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10Tetrapeptides
    • C07K5/1002Tetrapeptides with the first amino acid being neutral
    • C07K5/1016Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pyrane Compounds (AREA)
  • Lighting Device Outwards From Vehicle And Optical Signal (AREA)
  • Manipulator (AREA)
FI20050027A 1991-02-08 2005-01-11 Ei-terapeuttisesti käytettäviä trombiini-inhibiittoreita FI120690B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US07/652,929 US5240913A (en) 1989-08-18 1991-02-08 Inhibitors of thrombin
US65292991 1991-02-08
PCT/US1992/000836 WO1992013952A1 (en) 1991-02-08 1992-02-03 Improved inhibitors of thrombin
US9200836 1992-02-03

Publications (2)

Publication Number Publication Date
FI20050027L true FI20050027L (fi) 2005-01-11
FI120690B FI120690B (fi) 2010-01-29

Family

ID=24618783

Family Applications (2)

Application Number Title Priority Date Filing Date
FI924503A FI120348B (fi) 1991-02-08 1992-10-06 Menetelmä terapeuttisesti käyttökelpoisen trombiini-inhibiittorin valmistamiseksi
FI20050027A FI120690B (fi) 1991-02-08 2005-01-11 Ei-terapeuttisesti käytettäviä trombiini-inhibiittoreita

Family Applications Before (1)

Application Number Title Priority Date Filing Date
FI924503A FI120348B (fi) 1991-02-08 1992-10-06 Menetelmä terapeuttisesti käyttökelpoisen trombiini-inhibiittorin valmistamiseksi

Country Status (18)

Country Link
US (3) US5240913A (fi)
EP (1) EP0529031B9 (fi)
JP (1) JPH05506252A (fi)
KR (1) KR100259759B1 (fi)
AT (1) ATE193325T1 (fi)
AU (1) AU659828B2 (fi)
BG (1) BG61243B2 (fi)
CA (1) CA2079778C (fi)
DE (1) DE69231081T2 (fi)
DK (1) DK0529031T3 (fi)
ES (1) ES2149170T3 (fi)
FI (2) FI120348B (fi)
GR (1) GR3034257T3 (fi)
HU (1) HU218831B (fi)
NO (1) NO315710B1 (fi)
NZ (1) NZ241557A (fi)
TW (1) TW222642B (fi)
WO (1) WO1992013952A1 (fi)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5240913A (en) * 1989-08-18 1993-08-31 Biogen, Inc. Inhibitors of thrombin
US6060451A (en) * 1990-06-15 2000-05-09 The National Research Council Of Canada Thrombin inhibitors based on the amino acid sequence of hirudin
US5458568A (en) * 1991-05-24 1995-10-17 Cortrak Medical, Inc. Porous balloon for selective dilatation and drug delivery
US5811447A (en) 1993-01-28 1998-09-22 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6515009B1 (en) * 1991-09-27 2003-02-04 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US5656600A (en) * 1993-03-25 1997-08-12 Corvas International, Inc. α-ketoamide derivatives as inhibitors of thrombosis
US5599307A (en) * 1993-07-26 1997-02-04 Loyola University Of Chicago Catheter and method for the prevention and/or treatment of stenotic processes of vessels and cavities
CA2180140A1 (en) * 1993-12-27 1995-07-06 Jeffrey I. Weitz Methods and compositions for inhibiting thrombogenesis
WO1995019359A1 (en) * 1994-01-12 1995-07-20 Massachusetts Institute Of Technology Process for making xanthene or cubane based compounds, and protease inhibitors
US5510330A (en) * 1994-03-25 1996-04-23 Boehringer Mannheim Gmbh Combinations of thrombolytically active proteins and non-heparin anticoagulants, and uses thereof.
US5849510A (en) * 1994-04-26 1998-12-15 Selectide Corporation Factor Xa inhibitors
US6759384B1 (en) 1994-04-26 2004-07-06 Aventis Pharmaceuticals Inc. Factor Xa inhibitors
DE4430205A1 (de) 1994-08-26 1996-02-29 Behringwerke Ag Zusammensetzungen, die als Gegenmittel für Blut-Antikoagulanzien geeignet sind und deren Verwendung
DE4430204A1 (de) 1994-08-26 1996-02-29 Behringwerke Ag Arzneimittel, welches als Gegenmittel für Blut-Antikoagulanzien geeignet ist und seine Verwendung
US5747453A (en) 1995-06-06 1998-05-05 Alza Corporation Method for increasing the electrotransport flux of polypeptides
DE19549118C2 (de) * 1995-12-29 2000-07-13 Thomas W Stief Hämostaseaktivierungs-Inhibitor und Verfahren zum Hemmen der Hämostaseaktivierung in Blut oder anderen biologischen Flüssigkeiten
US6333189B1 (en) 1996-06-06 2001-12-25 Alza Corporation Method of making an electrotransport device
JPH1010784A (ja) * 1996-06-27 1998-01-16 Brother Ind Ltd 正帯電性一成分現像剤並びにその現像剤を用いた画像形成装置
GB9613719D0 (en) * 1996-06-29 1996-08-28 Thrombosis Res Inst Serine protease inhibitors
GB9613718D0 (en) * 1996-06-29 1996-08-28 Thrombosis Res Inst Thrombin inhibitors
US5840733A (en) 1996-07-01 1998-11-24 Redcell, Canada, Inc. Methods and compositions for producing novel conjugates of thrombin inhibitors and endogenous carriers resulting in anti-thrombins with extended lifetimes
US5985833A (en) * 1996-09-17 1999-11-16 Wisconsin Alumni Research Foundation Thrombin inhibitor
US20030077310A1 (en) 2001-10-22 2003-04-24 Chandrashekhar Pathak Stent coatings containing HMG-CoA reductase inhibitors
DE10162521A1 (de) * 2001-12-19 2003-07-17 Goetz Nowak Verwendung von molekulargewichtserweiterten Substanzen in der Tumortherapie
JP4903709B2 (ja) 2004-10-19 2012-03-28 ロンザ アーゲー 固相ペプチド合成のための方法
US7598343B1 (en) 2008-07-27 2009-10-06 The Medicines Company Pharmaceutical formulations of bivalirudin and processes of making the same
US7582727B1 (en) 2008-07-27 2009-09-01 The Medicinces Company Pharmaceutical formulations of bivalirudin and processes of making the same
KR101634830B1 (ko) 2008-09-03 2016-06-29 시노팜 타이완 리미티드 비발리루딘의 제조방법
US7803762B1 (en) 2009-08-20 2010-09-28 The Medicines Company Ready-to-use bivalirudin compositions
US7985733B1 (en) 2010-01-06 2011-07-26 The Medicines Company Buffer-based method for preparing bivalirudin drug product
GB201121513D0 (en) 2011-12-14 2012-01-25 Cambridge Entpr Ltd Thrombin-binding antibody molecules and uses thereof
US9518128B2 (en) 2011-12-14 2016-12-13 Janssen Pharmaceuticals, Inc. Thrombin-binding antibody molecules
AU2017273857B2 (en) 2016-06-01 2021-08-19 Athira Pharma, Inc. Compounds
WO2019030706A1 (en) 2017-08-10 2019-02-14 Janssen Pharmaceutica Nv ANTI-THROMBIN ANTIBODY MOLECULES AND METHODS OF USE IN ORTHOPEDIC SURGERY
WO2019035055A1 (en) 2017-08-16 2019-02-21 Janssen Pharmaceutica Nv ANTI-THROMBIN ANTIBODY MOLECULES AND METHODS OF USE WITH PLATELET ANTI-AGGREGATE AGENTS
US11992514B2 (en) 2019-05-20 2024-05-28 MAIA Pharmaceuticals, Inc. Ready-to-use bivalirudin compositions

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1161431A (en) * 1979-05-11 1984-01-31 Lars G. Svendsen Tripeptide derivatives
GB8305985D0 (en) * 1983-03-04 1983-04-07 Szelke M Enzyme inhibition
DE3501107A1 (de) * 1985-01-15 1986-07-17 Josef 8358 Vilshofen Paul Nutzfahrzeug mit schieberahmenwechselaufbau
CA1341032C (en) * 1987-01-23 2000-06-20 John L. Krstenansky Anticoagulant peptides
ZA883443B (en) * 1987-05-21 1988-11-16 Merrell Dow Pharmaceuticals Inc. Cyclic anticoagulant peptides
ZA883444B (fi) * 1987-05-21 1988-11-16
EP0333356A3 (en) * 1988-03-04 1990-12-19 Biogen, Inc. Hirudin peptides
US4971953A (en) * 1988-05-10 1990-11-20 Merrell Dow Pharmaceuticals Anticoagulant peptide alcohols
NZ228995A (en) * 1988-05-10 1992-03-26 Merrell Dow Pharma Hirudin peptide derivatives and pharmaceutical compositions
FI904330A7 (fi) * 1988-09-29 1990-09-03 Biogen Inc Hirudiinipeptidejä
US5196404B1 (en) * 1989-08-18 1996-09-10 Biogen Inc Inhibitors of thrombin
US5240913A (en) * 1989-08-18 1993-08-31 Biogen, Inc. Inhibitors of thrombin
AU654820B2 (en) * 1990-06-15 1994-11-24 Majesty (Her) In Right Of Canada As Represented By The National Research Council Of Canada Thrombin inhibitors based on the amino acid sequence of hirudin

Also Published As

Publication number Publication date
GR3034257T3 (en) 2000-12-29
FI120348B (fi) 2009-09-30
ES2149170T3 (es) 2000-11-01
AU1362192A (en) 1992-09-07
AU659828B2 (en) 1995-06-01
US5425936A (en) 1995-06-20
NO923889L (no) 1992-12-08
NO315710B1 (no) 2003-10-13
FI924503A7 (fi) 1992-10-06
NO923889D0 (no) 1992-10-07
WO1992013952A1 (en) 1992-08-20
BG61243B2 (bg) 1997-03-31
EP0529031A1 (en) 1993-03-03
FI120690B (fi) 2010-01-29
US5240913A (en) 1993-08-31
NZ241557A (en) 1996-11-26
JPH05506252A (ja) 1993-09-16
FI924503A0 (fi) 1992-10-06
KR100259759B1 (ko) 2000-06-15
TW222642B (fi) 1994-04-21
ATE193325T1 (de) 2000-06-15
DK0529031T3 (da) 2000-10-09
DE69231081T2 (de) 2001-02-01
EP0529031B1 (en) 2000-05-24
HU9203500D0 (en) 1993-01-28
EP0529031B9 (en) 2007-11-21
HU218831B (hu) 2000-12-28
CA2079778C (en) 2002-09-03
HK1005995A1 (en) 1999-02-05
HUT65675A (en) 1994-07-28
CA2079778A1 (en) 1992-08-09
DE69231081D1 (de) 2000-06-29
US5514409A (en) 1996-05-07

Similar Documents

Publication Publication Date Title
FI20050027L (fi) Ei-terapeuttisesti käytettäviä trombiini-inhibiittoreita
FI933303L (fi) Adenosinkinasinhibitorer
FI933277A7 (fi) Amiinidioli proteaasi-inhibiittorit
NO942064D0 (no) yminhibitorer
FI963597L (fi) Isoprenyylitransferaasi-inhibiittoreita
NO972930D0 (no) Fibronectin-adhesjonsinhibitorer
FI973282A0 (fi) Trombiinin inhibiittoreita
FI972160A0 (fi) Matriisimetalloproteaasi-inhibiittorit
ATE222240T1 (de) Hiv - protease inhibitoren
FI894748A7 (fi) Uusia peptidaasi-inhibiittoreita
DK0858464T3 (da) Thrombin-inhibitorer
DE59711714D1 (de) Thrombininhibitoren
BR8907457A (pt) Inibidores de interleucina-1
FI935644L (fi) Retrovirusten proteaasi-inhibiittoreita
FI895962A7 (fi) Proteaasi-inhibiittorit
IS3942A (is) Hálftilsniðinn hlutur
DE69210797D1 (de) Prolyl Endopeptidase Inhibitor
FI925696L (fi) Pao hirudinets aminosyrasekvens baserade trombininhibitorer
FI101796B1 (fi) Uusia -glukosidaasi-inhibiittoreita
FI952712L (fi) Protostomien syljestä saatu trombiini-inhibiittori
MX9100121A (es) Inhibidores de proteasas asparticas
DE69731664D1 (de) Thrombininhibitoren
DK174087D0 (da) Angiotensinkonverterende enzyminhibitor
DK69489D0 (da) Aspartattranscarbamylase-inhibitorer
NO922191L (no) Nye thrombininhibitorer

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 120690

Country of ref document: FI

MA Patent expired